Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2018 / Masters of the Bench

Masters of the Bench

Robert Samuel Langer
Robert Samuel Langer
Institute Professor, Massachusetts Institute of Technology, Langer Lab
Christopher J.H. Porter
Christopher J.H. Porter
Professor and Director, Monash Institute of Pharmaceutical Sciences
Carl June
Carl June
Richard W. Vague Professor in Immunotherapy, University of Pennsylvania
David Baltimore
David Baltimore
President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology
Roderick MacKinnon
Roderick MacKinnon
Scientific Co-Founder and Co-Chair, Flex Pharma
Nicholas A. Peppas
Nicholas A. Peppas
Professor and Director of the Institute for Biomaterials, Drug Delivery and Regenerative Medicine, The University of Texas at Austin
Shinya Yamanaka
Shinya Yamanaka
Director and Professor, Center for iPS Cell Research
Michael N. Liebman
Michael N. Liebman
Managing Director and Founder, IPQ Analytics LLC
Andreas Seidel-Morgenstern
Andreas Seidel-Morgenstern
Director, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg
Chi Van Dang
Chi Van Dang
Scientific Director, Ludwig Cancer Research
Phil S. Baran
Phil S. Baran
Darlene Shiley Chair in Chemistry, Scripps Research Institute
Jonathan Bones
Jonathan Bones
Principal Investigator, NIBRT Characterization and Comparability Laboratory
Chas Bountra
Chas Bountra
Professor of Translational Medicine, Nuffield Department of Clinical Medicine, University of Oxford
Carolyn Bertozzi
Carolyn Bertozzi
Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences, Stanford University
Jonas Boström
Jonas Boström
Principal Scientist, AstraZeneca; Chief Executive Officer, EduChem VR
Meindert Danhof
Meindert Danhof
Retired
David Dunger
David Dunger
Professor of Pediatrics, University of Cambridge
Kenneth Getz
Kenneth Getz
Associate Professor and Director of Sponsored Programs, Center for the Study of Drug Development, Tufts University School of Medicine; Founder and Board Chair, CISCRP
Graziella Pellegrini
Graziella Pellegrini
Cell Therapy Program Coordinator, center for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia
Claus-Michael Lehr
Claus-Michael Lehr
Head, Department of Drug Delivery, Helmholtz-Institute for Pharmaceutical Research Saarland, Helmholtz Center for Infection Research (HZI), Saarland University
Michele De Luca
Michele De Luca
Director, center for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia
Peter Seeberger
Peter Seeberger
Director, Max-Planck-Institute of Colloids and Interfaces; Professor, Free University of Berlin
Dolores Schendel
Dolores Schendel
Chief Executive Officer and Chief Scientific Officer, Medigene
Harold Varmus
Harold Varmus
Lewis Thomas University Professor & Senior Advisor to the Dean and Provost, Weill Cornell Medical College
John Talley
John Talley
Chief Scientific Officer, Euclises Pharmaceuticals

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.